Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021
Rachel Jaber Chehayeb(Yale University), Natalia Kunst(University of York), Rebecca A. Miksad(Brigham and Women's Hospital), Annette Hood(Yale New Haven Hospital), Maryam B. Lustberg(Yale Cancer Center), Xiaoliang Wang(Nanjing General Hospital of Nanjing Military Command), Shi‐Yi Wang(Beijing Forestry University), Rachel A. Greenup(Yale University), Sarah S. Mougalian(Yale Cancer Center), Lajos Pusztai(Yale University)
Cited by 18
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k